Participate

Your participation is crucial in helping us advance our development of potential treatments for Alzheimer’s Disease. Below we have outlined a few ways you can help contribute. Thank you for your support.

Available studies

Clinical Studies

New England, New Jersey, Atlanta and Florida

Cognito Therapeutics is enrolling in three clinical studies to study the effectiveness of this therapy in Alzheimer’s. Multiple locations are available. For more information, please email ClinicalStudy@cognitotx.com or to learn more, please visit these informational sites:  

Overture Study (multiple locations): https://clinicaltrials.gov/ct2/show/NCT03556280  

 

Etude Study (Boston only):

https://clinicaltrials.gov/ct2/show/NCT03661034  

 

Flicker Study (Atlanta only):

https://clinicaltrials.gov/ct2/show/NCT03543878

Translational Research

Boston, MA

Our Translational Research team is conducting studies in Boston to optimize the delivery and effectiveness of our technology. We are currently seeking participants for The RUBY Study and The GARNET Study. To learn more about each of these studies and to see if you qualify, click here.

User Experience Research

Global opportunities to participate

In order to design and develop products and services that best meet the needs of patients and care partners, our User Experience team regularly conducts user research. 

 

We recognize the importance of fostering a deep understanding of the complexities of the people and spaces for which we are designing. We are grateful for the opportunity to hear your experiences and perspectives to inform our focus.

 

To participate, please fill out this short form.

  Opportunities to participate: providing feedback on prototypes and ideas in development, interviews (remote and in-home), surveys, group workshops and more.